Item
Meg 3 Powder from DSM 5016227 (01-00183-1)
MEG-3 DHA K Powder 5016277
Food Ingredient
Locations
| Location name | Address |
|---|---|
| CATALENT PHARMA SOLUTIONS | 1100 Enterprise Drive Winchester, KY 40391 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | CATALENT PHARMA SOLUTIONS | Allergens.pdf | 10/23/2023 | 10/22/2025 |
| Country of Origin | CATALENT PHARMA SOLUTIONS | Country of Origin.pdf | 1/8/2024 | 1/7/2027 |
| Shelf Life | CATALENT PHARMA SOLUTIONS | Meg-3 DHA B Powder 5016227 PDS 2023 04 28.pdf | 4/28/2023 | 4/27/2025 |
| Pesticide | CATALENT PHARMA SOLUTIONS | Meg-3 DHA B Powder 5016227 PESTICDES 2017 04 28.pdf | 4/28/2017 | 4/28/2019 |
| GRAS/NDI/ODI Statement | CATALENT PHARMA SOLUTIONS | Meg-3 DHA B Powder 5016227 REGULATORY PACKET 2023 01 17.pdf | 1/17/2023 | 1/16/2026 |
| Product Specification Sheet | CATALENT PHARMA SOLUTIONS | Meg-3 DHA B Powder 5016227 REGULATORY PACKET 2023 01 17.pdf | 1/17/2023 | 1/16/2026 |
| BSE - TSE | CATALENT PHARMA SOLUTIONS | Meg-3 DHA B Powder 5016227 REGULATORY PACKET 2023 01 17.pdf | 1/17/2023 | 1/16/2026 |
| Safety Data Sheet (SDS) | CATALENT PHARMA SOLUTIONS | Meg-3 DHA B Powder 5016227 SDS 2019 11 14.pdf | 11/14/2019 | 11/13/2021 |
| California Prop. 65 | CATALENT PHARMA SOLUTIONS | MEG-3 DHA K Powder 5015277 PROP 65 2020 01 16.pdf | 1/16/2020 | 1/16/2029 |
| Suitability Requirements | CATALENT PHARMA SOLUTIONS | NotApplicable_SuitabilityRequirements.pdf | 1/4/2024 | 1/3/2027 |
